Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Revenue

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹13,980 Cr₹11,516 Cr₹10,728 Cr₹9,620 Cr₹8,508 Cr

What is the latest Revenue of TORRENT PHARMACEUTICALS ?

The latest Revenue ratio of TORRENT PHARMACEUTICALS is ₹13,980 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹13,980 Cr
Mar2025₹11,516 Cr
Mar2024₹10,728 Cr
Mar2023₹9,620 Cr
Mar2022₹8,508 Cr

How is Revenue of TORRENT PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹13,980 Cr
21.39
Mar2025 ₹11,516 Cr
7.35
Mar2024 ₹10,728 Cr
11.51
Mar2023 ₹9,620 Cr
13.07
Mar2022 ₹8,508 Cr -

Compare Revenue of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹186,972.3 Cr -1.3% -2.4% 33.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr -0.3% -3.1% 12.8% Stock Analytics
DIVIS LABORATORIES ₹251,531.0 Cr -1.3% 2.2% 57.5% Stock Analytics
CIPLA ₹111,729.0 Cr 0.2% -2.5% -9.1% Stock Analytics
MANKIND PHARMA ₹105,120.0 Cr 3.4% 6.6% -4.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,335.0 Cr 3.3% 6.1% -6.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-1.3%

-2.4%

33.3%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses